Medicinalproductdefinition-example-equilidem-basics.ttl

Basic details of a product, only using MedicinalProductDefinition and no other resources

@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/MedicinalProductDefinition/equilidem-basics> a fhir:MedicinalProductDefinition;
  fhir:nodeRole fhir:treeRoot;
  fhir:Resource.id [ fhir:value "equilidem-basics"];
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "generated" ];
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: equilidem-basics</p><p><b>identifier</b>: id: Equilidem25</p><p><b>combinedPharmaceuticalDoseForm</b>: <span>tablet</span></p><p><b>indication</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class &gt;= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.</p><p><b>legalStatusOfSupply</b>: <span>Prescription only medicine</span></p><p><b>classification</b>: <span>B01A</span></p><p><b>ingredient</b>: </p><ul><li><span>Equilidonium Phosphate</span></li><li><span>Calcium Carbonate</span></li></ul><h3>Names</h3><table><tr><td>-</td><td><b>ProductName</b></td></tr><tr><td>*</td><td>Equilidem 2.5 mg film-coated tablets</td></tr></table><h3>CrossReferences</h3><table><tr><td>-</td><td><b>Product</b></td></tr><tr><td>*</td><td/></tr></table><h3>ManufacturingBusinessOperations</h3><table><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><span>EquiliDrugCo Inc.</span></td></tr></table></div>"
  ];
  fhir:MedicinalProductDefinition.identifier [
     fhir:index 0;
     fhir:Identifier.system [ fhir:value "http://example.org.uk/fhir/product" ];
     fhir:Identifier.value [ fhir:value "Equilidem25" ]
  ];
  fhir:MedicinalProductDefinition.combinedPharmaceuticalDoseForm [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/dosefom" ];
       fhir:Coding.code [ fhir:value "tablet" ]
     ]
  ];
  fhir:MedicinalProductDefinition.indication [ fhir:value "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults."];
  fhir:MedicinalProductDefinition.legalStatusOfSupply [
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/legalstatusofsupply" ];
       fhir:Coding.code [ fhir:value "POM" ];
       fhir:Coding.display [ fhir:value "Prescription only medicine" ]
     ]
  ];
  fhir:MedicinalProductDefinition.classification [
     fhir:index 0;
     fhir:CodeableConcept.coding [
       fhir:index 0;
       fhir:Coding.system [ fhir:value "http://www.whocc.no/atc/example" ];
       fhir:Coding.code [ fhir:value "B01A" ]
     ]
  ];
  fhir:MedicinalProductDefinition.ingredient [
     fhir:index 0;
     fhir:Reference.display [ fhir:value "Equilidonium Phosphate" ]
  ], [
     fhir:index 1;
     fhir:Reference.display [ fhir:value "Calcium Carbonate" ]
  ];
  fhir:MedicinalProductDefinition.name [
     fhir:index 0;
     fhir:MedicinalProductDefinition.name.productName [ fhir:value "Equilidem 2.5 mg film-coated tablets" ]
  ];
  fhir:MedicinalProductDefinition.crossReference [
     fhir:index 0;
     fhir:MedicinalProductDefinition.crossReference.product [
       fhir:CodeableReference.reference [
         fhir:link <http://hl7.org/fhir/MedicinalProductDefinition/genericEquilidonium>;
         fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/genericEquilidonium" ]
       ]
     ]
  ];
  fhir:MedicinalProductDefinition.manufacturingBusinessOperation [
     fhir:index 0;
     fhir:MedicinalProductDefinition.manufacturingBusinessOperation.manufacturer [
       fhir:index 0;
       fhir:Reference.display [ fhir:value "EquiliDrugCo Inc." ]
     ]
  ] .

<http://hl7.org/fhir/MedicinalProductDefinition/genericEquilidonium> a fhir:MedicinalProductDefinition .

# - ontology header ------------------------------------------------------------

<http://hl7.org/fhir/MedicinalProductDefinition/equilidem-basics.ttl> a owl:Ontology;
  owl:imports fhir:fhir.ttl;
  owl:versionIRI <http://build.fhir.org/MedicinalProductDefinition/equilidem-basics.ttl> .

# -------------------------------------------------------------------------------------